Sensex, Nifty may try to rally after a minor dip: Monday Closing Report

More than a day’s correction may be needed to get back to a positive trend

The market, which was in the positive till noon trade, was hurtled into the red following remarks by S&P that India would be the first among BRIC nations to lose its investment grade rating. We had mentioned in our Friday’s closing report that Nifty may find its first resistance at 5,100, after which there may be a minor correction. Today the index crossed this level after which it slipped into the red during the last hour of trade. We may see the correction extending tomorrow, as well. However, if the negative move continues for more than a day, the downward trend may set in. Today the National Stock Exchange (NSE) saw a higher volume of 71.82 crore shares.

The market opened in the positive on news that the European Union, on Saturday, agreed to led up to 100 billion euros to Spain to help its beleaguered banks. The news also boosted the Asian markets in morning trade. The Nifty opened 29 points higher at 5,097 and the Sensex resumed trade at 16,805, up 86 points over its previous close.

The early gains were supported by banking, metal, power, auto and capital goods sectors which witnessed good buying interest. The upmove enabled the benchmarks hit their intraday highs in the first half hour itself with the Nifty going up to 5,124 and the Sensex rising to 16,894.

Meanwhile, the rupee rose by 32 paise to trade at 55.10 against the dollar in early trade as the greenback weakened against euro overseas.  The Indian unit had lost 48 paise to close at 55.42 against the dollar in the last session.

The market remained range-bound till the noon session after which strong selling pressure was the benchmarks pare all their gains and venture into the negative territory. The decline followed a warning from ratings agency Standard & Poor’s (S&P) that India might be the first among BRIC nations (Brazil, Russia, India and China) to lose its investment grade rating.

The news also saw the benchmarks fall to their day’s lows towards the end of trade. At this point, the Nifty dropped to 5,041 and the Sensex went back to 16,627.

The market ended the trading session marginally off the lows, snapping its five-day winning streak. At the close, the Nifty settled 14 points down at 5,054 and the Sensex lost 51 points to finish at 16,668.

The advance-decline ratio on the NSE was 802:739.

The broader markets closed on a mixed note. The BSE Mid-cap index dipped 0.20% while the BSE Small-cap index rose 0.21%.

BSE Consumer Durables (up 0.99%) and BSE Fast Moving Consumer Goods (up 0.19%) settled higher while all other sectoral indices ended in the red. They were led by BSE Capital Goods (down 1.64%); BSE Healthcare (down 1.34%); BSE Realty (down 1.02%); BSE Oil & Gas (down 0.75%) and BSE Auto (down 0.56%).

Tata Power (up 2.18%); Bajaj Auto (up 1.85%); Hindustan Unilever (up 1.58%); GAIL India (up 1.55%) and Coal India (up 1.44%) were the top gainers on the Sensex. The main losers were Cipla (down 2.25%); BHEL (down 2.21%); Larsen & Toubro (down 1.99%); Jindal Steel (down 1.93%) and Tata Motors (down 1.40%).

Tata Power (up 2.23%); Bajaj Auto (up 2.07%); Grasim Industries (up 1.55%); HUL (up 1.40%) and Siemens up 1.32%) were the key gainers on the Nifty. The main laggards were HCL Technologies (down 3.46%); BHEL (down 2.83%); Cipla (down 2.62%); Sesa Goa (down 2.52%) and L&T (down 2.40%).

Markets in Asia settled in the green on easing of banking concerns in Spain after EU leaders agreed to lend 100 billion euro to help Spanish banks deal with their liquidity issues. Positive economic data from China also supported the gains.

The Shanghai Composite climbed 1.07%; the Hang Seng surged 2.44%; the Jakarta Composite advanced 1.07%; the KLSE Composite rose 0.50%: the Nikkei 225 gained 1.96%; The Straits Times jumped 1.82%; the KOSPI Composite surged 1.71% and the Taiwan Weighted settled 1.72% higher.

At the time of writing, the key European indices were trading with gains of 0.97% to 1.95% and the US stock futures were in the positive.

Back home, foreign institutional investors were net buyers of shares totalling Rs202.01 crore on Friday while domestic institutional investors were net sellers of equities amounting to Rs81.48 crore.

Hinduja Group flagship firm Ashok Leyland today said it has supplied 100 ‘Falcon’ buses to Ghana for $7.6 million (about Rs42 crore). The vehicles have been inducted to the fleet of a transport company—Metro Mass Transit—in which the Government of Ghana has 45% stake. The buses will ply on 360 routes throughout Ghana, both inter and intra-city. The stock closed at Rs26.70 on the NSE, up 0.38% over its previous close.

Metkore Alloys & Industries is set to build a world-class 1,65,000 tonnes per annum capacity ferro chrome smelter project in Oman with an envisaged investment of $80 million. The company is negotiating with a local firm for a joint venture agreement, but no agreement has been signed so far. The stock surged 2.86% to close at Rs14.40 on the NSE.

The Dhampur Sugar Mills today said its board has approved the merger of JK Sugar with the company and shareholders of the latter will get 275 shares for every 1,000 shares they hold. The proposed merger is subject to regulatory and other approvals, the company added. Dhampur Sugar settled 1.35% higher at Rs45.20 on the NSE.


Alstom gets Rs55 crore order from NTPC for equipment supply


Alstom would supply complete station control equipments to NTPC's Solapur and Mauda projects in Maharashtra

New Delhi: French company Alstom has secured two contracts worth over Rs55 crore from state-run NTPC for supplying equipment to the state-run company's Solapur and Mouda projects in Maharashtra, reports PTI.
"These contracts worth Rs55.4 crore have been awarded to Power Automation and Controls (PAC) Business of the company in India," Alstom said in a statement.
The turnkey scope of the projects cover a combined area of complete station control to be manufactured by Alstom's manufacturing facilities in India and Europe.
While, the automation solutions for the project will be integrated locally by setting up a integration facilty in India, the electronic cards and assemblies will be manufactured by Alstom facilities in Europe, it said.
"The Power Automation and Controls business is a major component of Clean Power offering of Alstom," Francois Carpentier, Vice President, Thermal and Renewable Power, Alstom India.




4 years ago

no one is going ti die if we ban diesel passenger cars / SUVs altogether...


4 years ago

The price parity between petrole and diesel defenitely will make the car buyer to think twice before opting for a diesel one as petrole car offers maintainance advantage for city or urban living consumers. Diesel cars should be taxed to the level of making the subsidiaries for fuel equal. This would also create a level playing field between the car manifacturers. Thus a consumer who wants to travel long on road only would opt for diesel cars.

The Seema Rai case in Satyamev Jayate: Time to bell the cat?

The Seema Rai case of a failed pancreas transplant was discussed on Aamir Khan's Satyamev Jayate. Here is the full story of what went wrong in that case starting from the fact that Fortis did not even have the licence to perform pancreas transplant surgery

The case of Late Seema Rai presented by Major Pankaj Rai on the 27th May episode of Aamir Khan's TV show, Satyamev Jayate, has received a lot of attention during the last few days. Moneylife's article-The Indian Medical Association should indeed sue Aamir Khan! as a response to the above program, has called for reform in the medical sector including the creation of an effective network of accessible medical ombudsman. While the article per se did not focus on Late Seema Rai's case presented in the above show, several comments were received from esteemed Moneylife readers with regard to above case. And to understand the real issues behind the case, Moneylife explored several questions related to the case and these are shared below in question-answer format with necessary evidence and conclusions.
A.    As per the law, did the concerned hospital (Fortis) need to have a license to transplant organs such as pancreas in general? If so, did it as a hospital, have the required license for a pancreas transplant?

1.    Fortis did not have a certificate of registration (Form No 12) for performing pancreas transplant surgeries. Please see RTI response from the Government of Karnataka to this effect, given below as Exhibit # 1. The relevant portions are reproduced below

4 Can a license be granted to a hospital even if it does not apply specifically for that organ in Form 11? No
5 Does the license granted to Fortis Hospital on 25th March 2010 allow them to do pancreas transplant surgery? No


EXHIBIT # 1: Furnishing Information under RTI, Government of Karnataka, Dept of Health and Family Welfare Services


2.    The certificate of registration (exhibit # 2) given by the Appropriate Authority for Organ Transplantation to Fortis Hospital is attached and as can be seen from it. The certificate given to Fortis is for transplant of kidney, liver and homograft (permitted usage only).

EXHIBIT # 2: Certificate of Registration for Fortis Hospital  


3.    Please see exhibit # 3 for certificate of registration given to BGS Global which lists Pancreas separately. The certificate given to BGS global is for transplant of Kidney - Liver- Pancreas

EXHIBIT # 3: Certificate of registration for BGS Global received from the Government of Karnataka


4.    Fourth, there was an appeal before the appellate authority and secretary to government, health & family welfare department, vide APPEAL NO: HFW 304 FPR 2011. The appeal was between

M/s Fortis Hospital,            ……………………        Appellant
154/9, Bannerghatta Road,
Opp. I.I.M.B., Bangalore-78.

1)    Maj.Pankaj Rai (Retd.)            …………………….        Respondents
No.211, Best Township,
S. Medahalli (Opp. Punjabi Dhaba)
Sarjapur, Attibele Road,

2)    Appropriate Authority under The Transplantation of Human
Organs Act, 1994, Directorate of Health and Family Welfare Services,
Ananda Rao Circle, Bangalore-9.

The Appeal was made under Section 17 of the Transplantation Of Human Organs Act, 1994. And I am quoting from this appeal order, dated 24 November 2011, given by EV Ramana Reddy, appellate authority & secretary to government, health and family welfare department, who notes that:

"3.5  I am of the opinion that the appellant hospital (Fortis) does not have license for transplantation of "pancreas". There is no basis for argument of the Appellant that liver includes pancreas and other abdominal organs. Not only the office of the appropriate authority in Karnataka but also the director general of health services, Government of India, have categorically stated that license granted for liver does not include "pancreas". If it was not specifically rejected under Section 15(2) of the Act, it was not specifically granted also. I agree with the contention of the Respondent-1 (Maj Pankaj Rai Retd) that there is no clause for "deemed approval" if something is not specifically rejected under the Act. Contention of the Appellant that Dr Ramesh, the then Joint Director (Medical) categorically stated that liver includes all other abdominal organs cannot be agreed to. There is no written proof for this and even if the then joint director (medical) were to give it in writing, it is in violation of the Act."

5.    Fifth, the report of the Karnataka Lokayukta (No.Compt/LOK/BCD/621/2010/ARE-1, Bangalore), Dated: 20 May, 2011, notes that:

"The appropriate authority has given permission to Fortis hospital to do transplantation of kidney, liver and homograft usage only (Page # 4)      

Thus the Fortis hospital has registered with the Appropriate Authority to undertake only for kidney, homograft and liver transplantation surgeries only and not for pancreas (Page # 5)

Section 13 of Human Transplantation Act is violated by the Appropriate Authority as the Appropriate Authority has not conducted periodic inspections of the Fortis Hospital and has failed to look at the website of the Hospital.(Page # 6)

The hospital authorities have violated Sec. 9 of the Human Transplantation Act as they have allowed Dr Ramacharan Thaigarajan to perform pancreatic transplantation in spite of not having the permission to undertake pancreatic transplantation surgery in their hospital. (Page # 6)"

B.    The 2nd question is whether Late Seema Rai had registered for a pancreas transplant? If yes, when had she registered and where? A related question is whether a pancreas transplant was done on her along with the kidney transplant? When? Which hosiptal?

1.    According to Maj Pankaj Rai (Retd), Late Seema Rai had not registered for a pancreas transplant. Despite this, it was transplanted on her on 2 May 2010 at Fortis Hospital, Bannerghatta Road, Bangalore.

2.    Interestingly, the ZCCK (Zonal Coordination Committee of Karnataka for Transplantation) in a letter (page 1, point 2) to Major Pankaj Rai claims that it was not aware of the fact that Fortis did not have a valid transplant license (to undertake PANCREAS transplantation). The ZCCK also notes (Page 2, point 3) that "There are no rules laid down wherein a patient can be allocated organs even if he/she has not registered for the same". The letter is enclosed as Exhibit # 4 below. This clearly means that when a patient has not registered for transplant of a specific organ, there are no rules under the act to allocate the specific organ to the said patient.

3.    It is also very strange and ironical that ZCCK says that it was not aware that Fortis did not have a valid pancreas transplant license. This is because the Dr Ramcharan T, who is listed as the medical coordinator on ZCCK's letter head also happened to be the transplant surgeon at Fortis (at that point in time). Besides, the fact that Dr Ramcharan T was part of the ZCCK (authorization committee) does show that there was a significant conflict of interest and in fact, his presence in the authorization committee appears to be a violation of the The Transplantation of Human Organs Act (THOA)

4.  Specifically, The Transplantation of Human Organ Rules, 1995
Rule 4A talks about the authorisation committee-(1) The medical practitioner who will be part of the organ transplantation team for carrying out transplantation operation shall not be a member of the authorisation committee constituted under the provisions of clauses (a) and (b) of sub-section (4) of section 9 of the Act.

EXHIBIT # 4: Letter from the Zonal Coordination Committee of Karnataka for Transplantation (ZCCK)

To summarise, all of the above clearly establish the following basic facts:

a. FORTIS was required to have a specific certificate of registration (Form No 12)  to undertake PANCREAS transplantation

b. However, FORTIS did not have such a certificate of registration (Form No 12) necessary to undertake PANCREAS transplantation

c. Late Seema Rai had not registered for a PANCREAS transplant and so, there are NO rules under the law to allocate her a PANCREAS according to ZCCK. Yet, the ZCCK allotted her a PANCREAS. In fact, the role of ZCCK in all of this needs to be carefully and thoroughly probed.

d. Despite the lack of a certificate of registration (Form no 12) to perform a PANCREAS transplantation, and despite the fact that Late Seema Rai had not registered for a PANCREAS transplant, it is clear that FORTIS carried out the PANCREAS transplant on Late Seema Rai - on 2nd May 2010 – who unfortunately passed away on 6th May 2010

e. It must also be noted that Late Seema Rai’s death was not reported by FORTIS as required by law within 7 Days

f. While FORTIS Doctors have claimed that they had the patient’s consent (Please see mail from Dr Sreedhara in circulation), Maj Pankaj Rai has refuted the same. He argues that there was no informed consent. The questions that arise here are twofold:

i.   Even if a consent had been obtained from the patient, was this valid given that the PANCREAS transplant done by FORTIS itself was illegal; and

ii.   Put differently, would a patient and/or their family have consented, if they had known that the PANCREAS transplant, to be done by the FORTIS hospital, was being performed illegally?

These and other such issues - like the conflict of interest in the authorization committee and its composition being a violation of the Act - need to be better explored by the law enforcing agencies

g. Overall, the PANCREAS transplantation carried out by FORTIS on Late Seema Rai on 2nd May 2010 does not appear to be LEGAL. Without any doubt, this case certainly merits the highest levels of enquiry (either Judicial and/or by independent bodies like the CBI) for possible lapses on many counts in the law – ranging from illegal transplantation of organs like PANCREAS to functioning and composition of the authorization committees (with huge conflicts of interest and in contravention of the said Act) and even possible negligence by regulators of the relevant Act.

It must be remembered that in recent times, Hon Courts have suggested that strong action must be taken against regulators if they are found to neglect their regulatory duties. I wonder if that has been the case here. Again, only an independent enquiry will reveal the real facts. Therefore, the Government of India and Government of Karnataka should immediately take up the relevant issues and ensure that appropriate action is taken against all those people who violated the law - both in letter and spirit - in the present case.

And before I sign off, a sincere thanks to all those involved in calling attention to this case as it has significant ramifications for organ transplant in India. It is about time that we belled the cat with regard to the rampant corruption in the Medical Profession in India and restore it to the good old days when it was nobility personified.



Maj Pankaj Rai

2 years ago

Fortis Hospital has practised the biggest fraud ever done in the healthcare industry. It could never have been granted registration for pancreas since it had never applied for it. It colluded with officials of the Regulatory Body in 2010 to commit forgery in their application forms by obliterating 'kidney' and 'heart' and 'pancreas' was inserted in the application in black ink (the entire application form was filled in blue ink). Secondly, it has been using photocopies of incomplete tampered documents to suppress another serious violation ~ quackery. In addition to the Hospital not having registration for pancreas, the transplant surgeon was never authorised to perform pancreatic transplantation. Dr Thiagarajan the transplant surgeon's registration has been cancelled by Medical Council of India, the writ petition of Fortis Hospital has been dismissed by High Court. Applications of perjury are pending against Dr Ramcharan Thiagarajan and Fortis in High Court. Criminal activities in Fortis Hospital are hardly surprising in Fortis (quackery/human organ trafficking/perjury/forgery/criminal collusion) given that the Chairman is himself under a cloud for spurious drugs. The Hospital may not be a good investment bet for good governance and integrity but is certainly par excellence in doctoring documents.

Maj Pankaj Rai

3 years ago

The truth is now out. Fortis Hospital did not have permission/registration for performing pancreatic transplant surgery for the simple reason - they did not apply for that and neither did they pay the prescribed fee. Dr Rajanna Sreedhara and Dr Ramcharan Thiagarajan (both of Fortis Hospital) are facing perjury applications in front of Karnataka Medical Councila and Karnataka High Court respectively.

Nagesh Kini

4 years ago

Remember PJ Thomas was similarly appointed at the centre and it took a PIL to get him step down?


4 years ago

Height of brazenness! This pliable bureaucrat needs to be shown the door like PJ Thomas.

We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)